Randomized controlled trial of S-1 maintenance therapy in metastatic esophagogastric cancer – the multinational MATEO study

BACKGROUND: The optimal duration of firstline chemotherapy in metastatic esophagogastric cancer is unknown. In most clinical trials therapy was given until tumour progression or limiting toxicity. Maintenance concepts aiming to prolong the duration of response and maintain quality of life have been...

Descripción completa

Detalles Bibliográficos
Autores principales: Haag, Georg-Martin, Stocker, Gertraud, Quidde, Julia, Jaeger, Dirk, Lordick, Florian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5537937/
https://www.ncbi.nlm.nih.gov/pubmed/28760152
http://dx.doi.org/10.1186/s12885-017-3497-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5537937/
https://www.ncbi.nlm.nih.gov/pubmed/28760152
http://dx.doi.org/10.1186/s12885-017-3497-9

Ejemplares similares